Company Filing History:
Years Active: 2021-2023
Title: Innovations by Peter Zerhouni in the Field of Inflammatory Bowel Disease Treatment
Introduction
Peter Zerhouni is an accomplished inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory bowel diseases. With a total of three patents to his name, Zerhouni's work is paving the way for innovative therapeutic solutions.
Latest Patents
Zerhouni's latest patents include a groundbreaking oligonucleotide designed for the treatment of inflammatory bowel disease in human subjects. This invention provides a specific sequence, 5'-GGAACAGTTCGTCCATGGC-3' (SEQ ID NO:2), which is administered in doses ranging from 100 mg to 350 mg on at least four separate occasions, each a week apart. Additionally, he has developed a formulation and capsule suitable for oral administration, aimed at treating conditions such as ulcerative colitis and Crohn's disease.
Career Highlights
Peter Zerhouni is currently associated with Index Pharmaceuticals AB, where he continues to innovate in the medical field. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic methods.
Collaborations
Zerhouni collaborates with talented professionals in his field, including Arezou Zargari and Charlotte Admyre. Their combined expertise contributes to the development of effective treatments for inflammatory bowel diseases.
Conclusion
Peter Zerhouni's contributions to the treatment of inflammatory bowel diseases through his innovative patents highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in therapeutic solutions for patients.